Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

计划入组 3,430 人 · 首次发布于 2013 年 2 月 15 日

The Effects of Trigger Point Treatment in Temporomandibular Joint Dysfunction

计划入组 42 人 · 首次发布于 2019 年 10 月 10 日

A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects

计划入组 14 人 · 首次发布于 2016 年 5 月 23 日

Sugaheal variant

NRAS Inhibitor(Covant)

Inflammation (Variant Bio)

Pliant Therapeutics

United States

Vortant Technologies, LLC

United States

Roivant Sciences Ltd.

United States

Voiant's Imaging Endpoints Support FDA Approval of New Treatments for Colorectal Cancer and Glioma

Pimicotinib Demonstrates Significant Efficacy in Phase 3 Trial for Tenosynovial Giant Cell Tumor

Roivant Launches Pulmovant with In-Licensed Bayer Drug for Pulmonary Hypertension